SOX2 and metastatic neoplasm: Belotte et al reported that tumors with SOX2 amplification had statistically significant improved survival [9]; however, an earlier study from Wang et al reported that high SOX2 levels in both primary and metastatic tumor components statistically correlated with significantly worse survival [52].